Comprehensive analysis of ERCC3 prognosis value and ceRNA network in AML

• Published in: Clinical & translational oncology Vol. 25; no. 4; pp. 1053 - 1066
• Main Authors: Bao, Xiebing, Chen, Yao, Lou, Xiao, Du, Jiahui, Li, Huijun, Liu, Nian, Tang, Zaixiang, Hua, Jingsheng, Guo, Weiqiang, Liu, Song-Bai
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.04.2023
• Subjects: Adult; Chronic Disease; DNA Repair; Epigenesis, Genetic; Humans; Leukemia, Myeloid, Acute - pathology; Medicine; Medicine & Public Health; Oncology; Prognosis; Research Article; AML; ceRNA network; ERCC3; m; A RNA methylation; Prognostic biomarker; m6A RNA methylation

Background Acute myeloid leukemia (AML) is a hematological malignancy with high molecular and clinical heterogeneity, and is the most common type of acute leukemia in adults. Due to limited treatment options, AML is prone to relapse and has a poor prognosis. Excision repair cross-complementing 3 (ER...